Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

6,161 recalls · Class II, newest first

Class II · Moderate risk

Vancomycin HCL

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0623-2016
Class II · Moderate risk

Dextrose-NaCl

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0620-2016
Class II · Moderate risk

Intralipid

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0618-2016
Class II · Moderate risk

Solumedrol

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0617-2016
Class II · Moderate risk

Cefazolin

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0615-2016
Class II · Moderate risk

Sod Chloride

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0613-2016
Class II · Moderate risk

Zinc Sulfate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3226-07 D-0294-2016
Class II · Moderate risk

Voriconazole Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2815-10 D-0293-2016
Class II · Moderate risk

Vitamin D3 in Olive Oil

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3277-06 D-0292-2016
Class II · Moderate risk

Vancomycin Ophthalmic PF 0.5 mL

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-0209-64 D-0291-2016
Class II · Moderate risk

Tropicamide 1%/Phenylephrine 2.5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk

Tropicamide 0.5%/ Phenylephrine 5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk

Tri-Mix 30/1/10

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3256-05 D-0288-2016
Class II · Moderate risk

Triamcinolone diacetate USP PF

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3206-01 D-0287-2016

Recalls by year